Instead, as the coronavirus spread, the company manufactured commercial versions of the ventilator at its factory outside Pittsburgh and sold them for far higher prices overseas.
The subcommittee has asked the firm to detail the differences between the stockpile ventilator and the commercial version.
It has asked how many ventilators Philips has sold, at what prices and to whom since September 2019, the month that HHS placed its order for stockpile ventilators.
He said that the company had only made the stockpile ventilator in small batches and did not want to ramp up production on a product that had not been mass produced.
Instead, it is increasing production of the more expensive commercial version.